Inhaled medicines: past, present, and future

S Anderson, P Atkins, P Bäckman, D Cipolla… - Pharmacological …, 2022 - ASPET
The purpose of this review is to summarize essential pharmacological, pharmaceutical, and
clinical aspects in the field of orally inhaled therapies that may help scientists seeking to …

Pharmacology and therapeutics of bronchodilators revisited

MG Matera, CP Page, L Calzetta, P Rogliani… - Pharmacological …, 2020 - ASPET
Bronchodilators remain the cornerstone of the treatment of airway disorders such as asthma
and chronic obstructive pulmonary disease (COPD). There is therefore considerable interest …

[图书][B] Veterinary pharmacology and therapeutics

JE Riviere, MG Papich - 2018 - books.google.com
Veterinary Pharmacology and Therapeutics, Tenth Edition is a fully updated and revised
version of the gold-standard reference on the use of drug therapy in all major veterinary …

β2-Agonist Therapy in Lung Disease

M Cazzola, CP Page, P Rogliani… - American journal of …, 2013 - atsjournals.org
β2-Agonists are effective bronchodilators due primarily to their ability to relax airway smooth
muscle (ASM). They exert their effects via their binding to the active site of β2-adrenoceptors …

Executive summary: Japanese guidelines for adult asthma (JGL) 2021

A Niimi, K Fukunaga, M Taniguchi… - Allergology …, 2023 - jstage.jst.go.jp
abstract Asthma is characterized by chronic airway inflammation, variable airway narrowing,
and sensory nerve irritation, which manifest as wheezing, dyspnea, chest tightness, and …

Efficacy and safety of aclidinium bromide/formoterol fumarate fixed-dose combinations compared with individual components and placebo in patients with COPD …

D Singh, PW Jones, ED Bateman, S Korn… - BMC pulmonary …, 2014 - Springer
Background Aclidinium/formoterol is a twice-daily (BID) fixed-dose combination (FDC) in
development for chronic obstructive pulmonary disease (COPD). The efficacy and safety of …

Therapeutic approaches to asthma–chronic obstructive pulmonary disease overlap syndromes

PJ Barnes - Journal of Allergy and Clinical Immunology, 2015 - Elsevier
The recognition that there are some patients with features of asthma and chronic obstructive
pulmonary disease (COPD) has highlighted the need to develop more specific treatments for …

Mucus hypersecretion in chronic obstructive pulmonary disease and its treatment

BK Shah, B Singh, Y Wang, S Xie… - Mediators of …, 2023 - Wiley Online Library
Most patients diagnosed with chronic obstructive pulmonary disease (COPD) present with
hallmark features of airway mucus hypersecretion, including cough and expectoration …

Aerosol pulmonary immune engineering

ER Sudduth, M Trautmann-Rodriguez, N Gill… - Advanced Drug Delivery …, 2023 - Elsevier
Aerosolization of immunotherapies poses incredible potential for manipulating the local
mucosal-specific microenvironment, engaging specialized pulmonary cellular defenders …

Diagnosis and pharmacotherapy of stable chronic obstructive pulmonary disease: the Finnish guidelines

H Kankaanranta, T Harju, M Kilpeläinen… - Basic & clinical …, 2015 - Wiley Online Library
Abstract The Finnish Medical Society Duodecim initiated and managed the update of the
Finnish national guideline for chronic obstructive pulmonary disease (COPD). The Finnish …